Date: August 31, 2026
The Indian corporate sector witnessed several notable announcements this week, spanning chemicals, engineering, logistics, and advertising.
Thirumalai Chemicals Ltd has approved the sale of up to 14,60,000 equity shares, representing 5% of the total capital, in Ultramarine & Pigments Ltd. The transaction, expected to conclude within seven working days, will reduce Thirumalai’s holding from 14.38% (41,98,837 shares). The company confirmed the sale is not a related party transaction.
Sathlokhar Synergys E&C Global Ltd commenced trial production at its new Pre-Engineered Building (PEB) manufacturing unit in Tamil Nadu on August 30, 2026. With a monthly capacity of 1,200 MT, commercial production is slated for November 2026. The ₹69.9 crore project, funded via internal accruals, preferential issue proceeds, and bank finance, is expected to enhance in-house PEB manufacturing, improve execution speed, reduce costs, and strengthen EPC offerings.
Exim Routes Ltd has rescheduled its 7th Annual General Meeting (AGM) to September 23, 2026, from the earlier date of September 18. The meeting will be conducted via Video Conferencing (VC) and Other Audio Visual Means (OAVM). The Board also approved presenting the "Exim Routes ESOP Plan 2025" to shareholders, ensuring SEBI compliance and addressing NSE observations.
Signpost India Ltd announced a dividend of ₹0.50 per equity share for FY26, with tax deduction at source (TDS) applicable. Resident shareholders with PAN will face 10% TDS if dividends exceed ₹10,000, while those without PAN and non-residents will face 20%. Shareholders must submit required forms by September 11, 2026, to claim exemptions or lower rates.
Additionally, Thirumalai Chemicals Ltd reported that M/s. Walker Chandiok & Co LLP has resigned as statutory auditors of its subsidiary, TCL Intermediates Pvt Ltd, effective August 28, 2026. The move aligns with mandatory auditor rotation and ensures consistency with the holding company’s auditors.
Disclaimer: The information provided in this article is for informational purposes only and should not be considered financial or investment advice. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.
